Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Edu... more
FAQs about GRACEcast:How many episodes does GRACEcast have?The podcast currently has 625 episodes available.
July 22, 2013HPV in Head and Neck Cancer, Part 2: Caveats and Emerging Trials (video)Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population....more15minPlay
July 22, 2013HPV in Head and Neck Cancer, Part 2: Caveats and Emerging Trials (audio)Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population....more15minPlay
July 22, 2013HPV in Head and Neck Cancer, Part 1: What is it and What Does it Mean? (video)Dr. Jared Weiss from the University of North Carolina, Chapel Hill introduces us to the human papilloma virus and its role as a cause and relevant prognostic factor for head and neck cancer (HNSCC)....more8minPlay
July 22, 2013HPV in Head and Neck Cancer, Part 1: What is it and What Does it Mean? (audio)GRACE, cancerGRACE, GRACEcast, Jared Weiss, Unveristy of North Carolina-Chapel Hill, UNC-Chapel Hill, induction therapy, neoadjuvant therapy, head and neck cancer, HNSCC, carbplatin, paclitaxel, cetuximab, Taxol, Erbitux, weekly...more8minPlay
July 21, 2013Induction Chemotherapy for Head and Neck Cancer, Part 2: New Concepts Moving Forward (video)Dr. Jared Weiss from the University of North Carolina, reviews several options as induction therapy for head and neck cancer and focuses on the potential appeal and tolerability of the combination of weekly carboplatin and paclitaxel with cetuximab....more14minPlay
July 21, 2013Induction Chemotherapy for Head and Neck Cancer, Part 2: New Concepts Moving Forward (audio)Dr. Jared Weiss from the University of North Carolina, reviews several options as induction therapy for head and neck cancer and focuses on the potential appeal and tolerability of the combination of weekly carboplatin and paclitaxel with cetuximab....more14minPlay
July 18, 2013Induction Chemotherapy for Head and Neck Cancer, Part 1: Defining the Challenges (video)Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews the rationale for induction chemotherapy before surgery for head and neck cancer and highlights the early work that led to the emergence of the TPF regimen in this setting....more10minPlay
July 18, 2013Induction Chemotherapy for Head and Neck Cancer, Part 1: Defining the Challenges (audio)Dr. Jared Weiss from the University of North Carolina, Chapel Hill reviews the rationale for induction chemotherapy before surgery for head and neck cancer and highlights the early work that led to the emergence of the TPF regimen in this setting....more10minPlay
July 11, 2013Dr. Ravi Salgia: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing?Dr. Ravi Salgia, from the University of Chicago, describes which patients with advanced non-small cell lung cancer he would recommend getting a repeat biopsy to obtain sufficient tissue to perform molecular marker testing....more3minPlay
July 11, 2013Dr. Sarah Goldberg: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers?Dr. Sarah Goldberg gives her view on more widespread availability of new mutation tests, provides her perspective on the likelihood that molecular oncology principles and targeted therapies will become more broadly applicable for other LC subtypes....more3minPlay
FAQs about GRACEcast:How many episodes does GRACEcast have?The podcast currently has 625 episodes available.